New treatment offers promise of relief for migraine sufferers
/cloudfront-us-east-1.images.arcpublishing.com/gray/CFR47U2YF5JPHOFGF2JJ76HWDI.jpg)
A migraine treatment is providing relief for people who suffer from migraines.
The medication is best described as an injectable pain reliever, and it’s taken only once a month.
Neurologist Dr. Mark Schwartze at Baylor Scott & White Hillcrest Medical Center says this is one of best treatments to date.
The drug blocks the gene that triggers migraines stopping them in their tracks.
The calcitonin related peptide CGRP, causes inflammation in the brain leading to migraines.
“Many of the patients we have been seeing were using Botox. Botox is a good treatment, still is a good treatment and can be used in concert with the CGRP blocker, but the CGRP is one of the best treatments and it really has changed the game for curing for migraine,” Schwartze said.
The medication’s injector is used much as an Epi-Pen.
There are two CGRP blockers doctors are now prescribing called Aimovig and Emgality.
Schwartze believes this medication is effective because it doesn't have many side effects and goes well with other medications.